MTNB - Matinas BioPharma Holdings, Inc.
0.5282
-0.007 -1.287%
Share volume: 2,764
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | |
| Report Date | 05-10-2023 | 08-09-2023 | 11-08-2023 | 03-27-2024 | 11-13-2024 | |
| Assets | ||||||
| Total Assets | 38.262 M | 34.025 M | 29.791 M | 25.104 M | 20.577 M | |
| Current Assets | 28.206 M | 24.000 M | 19.989 M | 15.543 M | 11.741 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.299 M | 1.437 M | 1.723 M | 1.737 M | 0.000 | |
| Short Term Investments | 3.299 M | 1.437 M | 1.723 M | 1.737 M | 500.000 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 24.857 M | 22.513 M | 18.216 M | 13.756 M | 10.295 M | |
| Total Non-current Assets | 10.056 M | 10.025 M | 9.802 M | 9.561 M | 0.000 | |
| Property Plant Equipment | 1.998 M | 2.103 M | 2.021 M | 1.923 M | 1.648 M | |
| Other Assets | 3.505 M | 3.369 M | 3.228 M | 3.085 M | 7.188 M | |
| Intangible Assets | 3.017 M | 3.017 M | 3.017 M | 3.017 M | 0.000 | |
| Goodwill | 1.336 M | 1.336 M | 1.336 M | 1.336 M | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 38.262 M | 34.025 M | 29.791 M | 25.104 M | 20.577 M | |
| Total liabilities | 5.637 M | 6.171 M | 6.641 M | 5.858 M | 4.798 M | |
| Total current liabilities | 1.896 M | 2.589 M | 3.229 M | 2.622 M | 2.124 M | |
| Accounts Payable | 516.000 K | 604.000 K | 835.000 K | 514.000 K | 349.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 2.319 M | |
| Current long term debt | 589.000 K | 613.000 K | 637.000 K | 661.000 K | 0.000 | |
| Long term debt | 3.400 M | 3.241 M | 3.071 M | 2.895 M | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 2.319 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 32.625 M | 27.854 M | 23.150 M | 19.246 M | 15.779 M | |
| Common stock | 217.265 M | 217.265 M | 217.265 M | 217.265 M | 207.170 M | |
| Retained earnings | -158.144 M | -164.204 M | -170.259 M | -175.573 M | -191.391 M |